Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 6, 2008, Pages 261-270

  Gorska, K ^a   Krenke, R ^a   Korczynski, P ^a   Kosciuch, J ^a   Domagala Kulawik, J ^a   Chazan, R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Asthma; COPD; Eosinophilic inflammation; Induced sputum

Indexed keywords

METHACHOLINE; DIAGNOSTIC AGENT; HYPERTONIC SOLUTION;

ADULT; AIRWAY; ARTICLE; ASTHMA; CELL COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; LABORATORY TEST; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION TEST; MALE; PRICK TEST; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SPUTUM; SPUTUM ANALYSIS; ADOLESCENT; AGED; BODY MASS; FORCED EXPIRATORY VOLUME; INFLAMMATION; LEUKOCYTE COUNT; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; SMOKING; VITAL CAPACITY;

ADOLESCENT; ADULT; AGED; ASTHMA; BODY MASS INDEX; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERTONIC SOLUTIONS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM; SMOKING; SPUTUM; VITAL CAPACITY; YOUNG ADULT;

EID: 64549126027     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672-688.
2. Keatings VM, Collins PD, Scott DM et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with COPD or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
3. Siva R, Green R, Briqthlinq C et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J2007; 29: 906-913
4. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004;24: 822-833.
5. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993 Mar; 16: 1-100.
6. GINA Global Initiative for Asthma: Global strategy for asthma management and prevention. NHLBI/WHO 2002.
7. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report, 2001.
8. Sterk PJ, Fabbri LM, Quanjer PH et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 53-83.
9. Djukanovic R, Sterk PJ, Fahy JV, Hargreave FE. Standardised methodology of sputum induction and processing. Eur Respir J2002; 20, Suppl 37.
10. Gorska K, Krenke R, Kosciuch J et al. The relationship between markers of airway inflammation and thickness of the basement membrane in patients with asthma. Pneumonol Alergol Pol 2007; 75: 363-369.
11. Domagala-Kulawik J, Maskey-Warzechowska M, Hermanowicz J, Chazan R. Expression of macrophage surface markers in induced sputum of patients with chronic obstructive pulmonary disease. J Physiol Pharmacol 2006; 57 Suppl 4: 75-84.
12. Belda J, Leigh R, Parameswaran K et al. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161: 475-478.
13. Godon P, Boulet LP, Malo JL et al. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Eur Respir J 2002; 20: 1364-1369.
14. Richter K, Holz O, Jorres RA et al. Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease. Eur Respir J 1999; 14: 697-701.
15. Bousquet J, Jeffery PK, Busse WW et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720-1745.
16. ten Brinke A, Zwinderman AH, Sterk PJ et al. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164: 744-748.
17. Peleman R, Rytila P, Kips J et al. The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 839-843.
18. Chanez P, Vignola AM, O'Shaugnessy T et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997; 155: 1529-1534.
19. Postma DS, Boezen HM. Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004; 126 (Suppl 2): 96s-104s.
20. Saetta M, Di Stefano A, Maestrelli P et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150: 1646-1652.
21. Perng DW, Huang HY, Chen HM et al. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment. Chest 2004; 126: 375-381.
22. Rutgers SR, Postma DS, ten Hacken NH et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55: 12-18.
23. Leigh R, Pizzichini MM, Morris MM et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 2006; 27: 967-971.
24. +-24. Snoeck-Stroband J, Lapperre T, Gosman M et al. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J 2008; 31: 70-77.
25. Matsumoto K, Aizawa H, Inoue H et al. Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke. Eur Respir J 1998; 12: 387-394.
26. Burney PG, Britton JR, Chinn S et al. Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax 1987; 42: 38-44.
27. 1. Am J Respir Crit Care Med 1995; 151: 1377-1382.
28. Bahous J, Cartier A, Ouimet G et al. Nonallergic bronchial hyperexcitability in chronic bronchitis. Am Rev Respir Dis 1984; 129: 216-220.
29. Ramsdale EH, Morris MM, Roberts RS et al. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 1984; 39: 912-918.
30. Yan K, Salome GM, Woolcock AJ. Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132: 25-29.
31. Kanner RE, Connett JE, Altose MD et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 1994; 150:956-961.
32. Brutsche MH, Downs SH, Schindler C et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax 2006; 61: 671-677.
33. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-271.
34. Brightling CE, Ward R, Goh KL et al. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160: 406-410.